TechGuru,

I think in our case , since there are no serious side effects in either dose , they be looking at results..

And here I am not sure if they will consider and compare , mostly patients with longer overlap , or mixture ,,,
possibly it might be a little difference with those results depending what % of patients in each dose use longer overlap ...

We should know soon , hopefully we will know the dose FDA like better Tuesday or sooner...




IMO...